Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study

References

• Lynch JPI, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16(3):217–5. doi:10.1097/MCP.0b013e3283385653.
   PubMed Web of Science ®Google Scholar
• Scientific advisory on the optimal schedule for childhood immunization against pneumococcal disease in Québec. INSPQ. [accessed 2022 May 31]. https://www.inspq.qc.ca/es/node/11372.
   Google Scholar
• De Wals P, Lefebvre B, Deceuninck G, Longtin J. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. Vaccine. 2018;36(3):421–426. doi:10.1016/j.vaccine.2017.11.054.
   PubMed Web of Science ®Google Scholar
• Cinicola B, Conti MG, Terrin G, Sgrulletti M, Elfeky R, Carsetti R, Fernandez Salinas A, Piano Mortari E, Brindisi G, De Curtis M. et al. The protective role of maternal immunization in early life. Front Pediatr. 2021;9. doi:10.3389/fped.2021.638871.
   PubMed Web of Science ®Google Scholar
• Abu-Raya B, Maertens K, Munoz FM, Zimmermann P, Curtis N, Halperin SA, Rots N, Barug D, Holder B, Kampmann B. et al. The effect of tetanus-diphtheria-acellular-pertussis immunization during pregnancy on infant antibody responses: individual-participant data meta-analysis. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.689394.
   Web of Science ®Google Scholar
• Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H. et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis. 2015;61(11):1637–1644. doi:10.1093/cid/civ695.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Perrett KP, Messina NL, Donath S, Ritz N, van der Klis FRM, Curtis N. The effect of maternal immunisation during pregnancy on infant vaccine responses. EClinicalMedicine. 2019;13:21–30. doi:10.1016/j.eclinm.2019.06.010.
   PubMedGoogle Scholar
• Perrett KP, Halperin SA, Nolan T, Carmona Martínez A, Martinón-Torres F, García-Sicilia J, Virta M, Vanderkooi OG, Zuccotti GV, Manzoni P. et al. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial. Vaccine. 2020;38(8):2105–2114. doi:10.1016/j.vaccine.2019.10.104.
   PubMed Web of Science ®Google Scholar
• Barug D, Berbers GAM, van Houten MA, Kuijer M, Pronk I, Knol MJ, Sanders EAM, Rots NY. 2020. Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: an open-label, parallel, randomised controlled trial. Vaccine. 38(29):4632–9. doi:10.1016/j.vaccine.2020.04.001.
   PubMed Web of Science ®Google Scholar
• Peckeu L, van der Ende A, de Melker HE, Sanders EAM, Knol MJ. 2021. Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands. Vaccine. 39(2):431–7. doi:10.1016/j.vaccine.2020.11.018.
   PubMed Web of Science ®Google Scholar
• Maertens K, Burbidge P, Van Damme P, Goldblatt D, Leuridan E. 2017. Pneumococcal immune response in infants whose mothers received tetanus, diphtheria and acellular pertussis vaccination during pregnancy. Pediatr Infect Dis J. 36(12):1186–1192. doi:10.1097/INF.0000000000001601.
   PubMed Web of Science ®Google Scholar
• Voysey M, Kelly DF, Fanshawe TR, Sadarangani M, O’Brien KL, Perera R, Pollard AJ. 2017. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis. JAMA Pediatr. 171(7):637–46. doi:10.1001/jamapediatrics.2017.0638.
   PubMed Web of Science ®Google Scholar
• Public Health Act. LegisQuébec. [accessed 2023 July 10]. https://www.legisquebec.gouv.qc.ca/en/document/cs/S-2.2?&cible.
   Google Scholar
• Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine. 2016;34(1):142–150. doi:10.1016/j.vaccine.2015.10.100.
   PubMed Web of Science ®Google Scholar
• Rice TF, Diavatopoulos DA, Smits GP, van Gageldonk PGM, Berbers GAM, van der Klis FR, Vamvakas G, Donaldson B, Bouqueau M, Holder B. et al. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy – a prospective, observational cohort study from the United Kingdom. Clin Exp Immunol. 2019;197(1):1–0. doi:10.1111/cei.13275.
   PubMed Web of Science ®Google Scholar
• Ouldali N, Deceuninck G, Lefebvre B, Gilca R, Quach C, Brousseau N, Tapiero B, De Wals P. Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis. Lancet Reg Health Am. doi:10.1016/j.lana.2023.100448.
   Google Scholar
• Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries - PMC. [accessed 2022 Aug 29]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019979/.
   Google Scholar
• Anglemyer A, McNeill A, DuBray K, Sonder GJB, Walls T. 2022. Invasive pneumococcal disease: concerning trends in serotype 19A notifications in New Zealand. Clin Infect Dis. 74(10):1859–1861. doi:10.1093/cid/ciab766.
   PubMed Web of Science ®Google Scholar
• Desmet S, Lagrou K, Wyndham-Thomas C, Braeye T, Verhaegen J, Maes P, Fieuws S, Peetermans WE, Blumental S. 2021. Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study. Lancet Infect Dis. 21(1):127–36. doi:10.1016/S1473-3099(20)30173-0.
   PubMed Web of Science ®Google Scholar
• Pneumococcal conjugate vaccines: WHO position paper. [accessed 2023 Feb 7]. https://www.who.int/publications-detail-redirect/10665-310968.
   Google Scholar
• Pichichero ME, Khan MN, Xu Q. Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccines Immunother. 2016;12(1):194–205. doi:10.1080/21645515.2015.1052198.
   PubMed Web of Science ®Google Scholar
• Duke JA, Avci FY. Emerging vaccine strategies against the incessant pneumococcal disease. NPJ Vaccines. 2023;8(1). doi: 10.1038/s41541-023-00715-w.
   PubMed Web of Science ®Google Scholar
• Mirzaei B, Babaei R, Valinejad S. 2021. Staphylococcal vaccine antigens related to biofilm formation. Hum Vaccines Immunother. 17(1):293–303. doi:10.1080/21645515.2020.1767449.
   PubMed Web of Science ®Google Scholar
• Reiss-Mandel A, Regev-Yochay G. Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality? Hum Vaccines Immunother. 2016;12(2):351–7. doi:10.1080/21645515.2015.1081321.
   PubMed Web of Science ®Google Scholar
• Joubert IA, Otto M, Strunk T, Currie AJ. Look who’s talking: host and pathogen drivers of Staphylococcus epidermidis virulence in neonatal sepsis. Int J Mol Sci. 2022;23(2):860. doi:10.3390/ijms23020860.
   PubMed Web of Science ®Google Scholar
• Andrews N, Waight PA, Borrow R, Ladhani S, George RC, Slack MPE, Miller E. 2011. Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales. PloS One. 6(12):e28435. doi:10.1371/journal.pone.0028435.
   PubMed Web of Science ®Google Scholar